Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Gastric Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: MFE23 scFv-expressing autologous anti-CEA MFEz T lymphocytes|BIOLOGICAL: aldesleukin|DRUG: cyclophosphamide|DRUG: fludarabine phosphate|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Sponsor: Cancer Research UK